Sarah Boyce

Affiliations

  • President And Ceo at Avidity Biosciences Inc. (RNA), 2025-03-21
  • Director at Contineum Therapeutics Inc. (CTNM), 2024-06-24
  • Director at Omniab Inc. (OABI), 2024-06-21
  • Other at Ligand Pharmaceuticals Inc (LGND), 2022-11-04
  • Director at Berkeley Lights Inc. (BLI), 2021-05-19
  • President at Akcea Therapeutics Inc. (AKCA), 2019-07-17
  • Chief Business Officer at Ionis Pharmaceuticals Inc (IONS), 2018-01-18
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
OABI $2.92 15,000 $43,800.00 36,000 2022-11-10 Filing
OABI $2.74 21,000 $57,596.70 21,000 2022-11-09 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
RNA $31.06 31,540 $979,563.01 305,871 2025-03-20 Filing
RNA $28.59 5,659 $161,816.84 337,411 2025-01-21 Filing
RNA $28.59 4,738 $135,474.58 343,070 2025-01-21 Filing
RNA $32.66 31,855 $1,040,384.30 265,308 2024-12-18 Filing
RNA $44.00 32,880 $1,446,723.29 234,663 2024-09-23 Filing